Chemotherapy-intolerant
1 clinical trials · Condition
◉ Watch Chemotherapy-intolerant
| Record | Firm | Date |
|---|---|---|
| Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer (NCT06496373) | Ruijin Hospital | 2024-07-16 |
Track Chemotherapy-intolerant automatically
Every clearance here is in the API, with alerts when new ones post.